Doxorubicin is the best known and most widely used member of the anthracycline antibiotic group of anticancer agents. It was first introduced in the 1970s, and since that time has become one of the most commonly used drugs for the treatment of both hematological and solid tumors. 

[1] Sheela A Abraham et,al.The liposomal formulation of doxorubicin, Methods Enzymol. 2005;391:71-97. doi: 10.1016/S0076-6879(05)91004-5.